ROLE OF TUMOR NECROSIS FACTOR AND INTERLEUKIN-1 IN GAMMA-INTERFERON-PROMOTED ACTIVATION OF MOUSE TUMORICIDAL MACROPHAGES
- 15 May 1989
- journal article
- research article
- Vol. 49 (10) , 2606-2614
Abstract
The purpose of this study was to determine if recombinant murine interleukin 1.beta. (rMu-IL-1.beta.) alone or in combination with recombinant murine .gamma.-interferon (rMu-IFN-.gamma.) could activate murine macrophages to be tumoricidal against tumor necrosis factor (TNF)-insensitive target cells and to evaluate the possible role of interleukin 1 (IL-1) in murine macrophage activation by recombinant murine tumor necrosis factor (rMu-TNF) plus rMu-IFN-.gamma.. rMu-IL-1.beta. and rMu-TNF alone or in combination could neither directly lyse the TNF-insensitive P815 mastocytoma nor activate resident peritoneal macrophages to be tumoricidal for this target. A synergistic induction of tumoricidal macrophage activity against P815 occurred, however, when either of these monokines was combined with rMu-IFN-.gamma.. The tumoricidal activity obtained was transitory, and the level of activity was dependent upon the monokine concentration and the length of induction period. Murine macrophages stimulated under the same conditions used to induce tumoricial activity with rMu-TNF plus rMu-IFN-.gamma. or with rMu-IL-1 plus rMu-IFN-.gamma. were shown to produce low concentrations of IL-1 or TNF, respectively. Thus, a bidirectional cross-induction of the production of the two monokines occurred. The monokine production was also quite transitory, and the time of peak production of the monokines (12 h) was found to precede the time of peak tumoricidal activation (24 h). Using neurtralizing antisera specific for rMu-IL-1s and rMu-TNF, the cross-induced production of TNF was shown to be required for macrophage tumoricidal activation by rMu-IL-1.beta. alone (TNF-sensitive targets) or in combination with rMu-IFN-.gamma. (TNF-insensitive targets). There was no evidence, however, that the production of IL-1 was required for marcophage activation by rMu-TNF in combination with rMu-IFN-.gamma.This publication has 35 references indexed in Scilit:
- Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophagesBiochemical and Biophysical Research Communications, 1986
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity.The Journal of Immunology, 1985
- Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.The Journal of Immunology, 1985
- Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.The Journal of Immunology, 1984
- Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.The Journal of Immunology, 1983
- Preparation of goat antibodies against interleukin 1: use of an immunoadsorbent to purify interleukin 1.The Journal of Immunology, 1983
- Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon.The Journal of Immunology, 1983
- INTERFERON AS A MACROPHAGE ACTIVATING FACTOR .1. ENHANCEMENT OF CYTO-TOXICITY BY FRESH AND MATURED HUMAN-MONOCYTES IN THE ABSENCE OF OTHER SOLUBLE SIGNALS1983
- The differential effects of human leukocyte pyrogen/lymphocyte-activating factor, T cell growth factor, and interferon on human natural killer activity.The Journal of Immunology, 1982